Munich, Georgia

Peter Wutzler


 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Wutzler

Introduction

Peter Wutzler is a notable inventor based in Munich, Germany. He has made significant contributions to the field of antiviral agents, holding two patents that showcase his innovative approach to combating viral infections. His work is characterized by a focus on chemical compounds that demonstrate high efficacy against various viruses.

Latest Patents

Wutzler's latest patents include the development of 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives. These compounds are designed for use as antiviral active substances. The invention details a method for manufacturing these derivatives, which have shown particularly high activity against rhinoviruses and picornaviruses. Additionally, he has patented 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, which also serve as antiviral agents. Both patents emphasize the compounds' tolerability and potential for treating viral infections.

Career Highlights

Throughout his career, Peter Wutzler has worked with several prominent companies, including Scandion Oncology A/S and Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG. His experience in these organizations has contributed to his expertise in the development of pharmaceutical compounds.

Collaborations

Wutzler has collaborated with Michaela Schmidtke, enhancing his research and development efforts in the field of antiviral agents.

Conclusion

Peter Wutzler's innovative work in developing antiviral compounds has the potential to significantly impact the treatment of viral infections. His patents reflect a commitment to advancing medical science through effective and tolerable solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…